| Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth G Germano, S Lamba, G Rospo, L Barault, A Magrì, F Maione, M Russo, ... Nature 552 (7683), 116-120, 2017 | 621 | 2017 |
| Tumor evolution as a therapeutic target N Amirouchene-Angelozzi, C Swanton, A Bardelli Cancer discovery 7 (8), 805-817, 2017 | 219 | 2017 |
| Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target N Amirouchene-Angelozzi, F Nemati, D Gentien, A Nicolas, A Dumont, ... Molecular Oncology 8 (8), 1508-1520, 2014 | 159 | 2014 |
| The clinical impact of the genomic landscape of mismatch repair–deficient cancers G Germano, N Amirouchene-Angelozzi, G Rospo, A Bardelli Cancer discovery 8 (12), 1518-1528, 2018 | 110 | 2018 |
| Evolving neoantigen profiles in colorectal cancers with DNA repair defects G Rospo, A Lorenzato, N Amirouchene-Angelozzi, A Magrì, C Cancelliere, ... Genome medicine 11, 1-22, 2019 | 58 | 2019 |
| The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma N Amirouchene-Angelozzi, E Frisch-Dit-Leitz, G Carita, A Dahmani, ... Oncotarget 7 (17), 23633, 2016 | 54 | 2016 |
| Tumor evolution as a therapeutic target. Cancer Discov. 2017; 7: 805–817. doi: 10.1158/2159-8290 N Amirouchene-Angelozzi, C Swanton, A Bardelli CD-17-0343.[Abstract][CrossRef][Google Scholar], 0 | 26 | |
| The clinical impact of the genomic landscape of mismatch repair-deficient cancers. Cancer Discov. 2018; 8: 1518–1528. doi: 10.1158/2159-8290 G Germano, N Amirouchene-Angelozzi, G Rospo, A Bardelli CD-18-0150.[Abstract][CrossRef][Google Scholar], 0 | 16 | |
| Tumor evolution as a therapeutic target. Cancer Discov. 2017 doi: 10.1158/2159-8290 N Amirouchene-Angelozzi, C Swanton, A Bardelli CD-17-0343.[Abstract][CrossRef][Google Scholar], 0 | 15 | |
| Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial. S Siena, A Sartore-Bianchi, N Personeni, F Pietrantonio, G Germano, ... Journal of Clinical Oncology 37 (15_suppl), TPS2659-TPS2659, 2019 | 12 | 2019 |
| Upcoming translational challenges for uveal melanoma N Amirouchene-Angelozzi, M Schoumacher, MH Stern, N Cassoux, ... British Journal of Cancer 113 (12), 1746, 2015 | 8 | 2015 |
| Uveale Melanomzellen unter oxidativem Stress–Einfluss von VEGF und VEGF-Inhibitoren M Dithmer, AM Kirsch, L Gräfenstein, F Wang, H Schmidt, SE Coupland, ... Klinische Monatsblätter für Augenheilkunde 236 (03), 295-307, 2019 | 7 | 2019 |
| The mTOR inhibitor everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma. Oncotarget. 2016; 7: 23633–46 N Amirouchene-Angelozzi, E Frisch-Dit-Leitz, G Carita, A Dahmani, ... | 2 | |
| Patient-reported outcomes (PROs) and biomarker assessments in daNIS-3, a phase II platform study of NIS793 (anti–TGF-β monoclonal antibody) and other investigational drug … S Kopetz, S Kasper, F Rivera, C Tournigand, Y Cheng, P Deshpande, ... Journal of Clinical Oncology 41 (4_suppl), TPS272-TPS272, 2023 | | 2023 |
| Abstract CT214: AlfaOmega-a master protocol empowering precision research in colorectal cancer L Lazzari, P Luraghi, N Amirouchene-Angelozzi, A Bertotti, E Medico, ... Cancer Research 79 (13_Supplement), CT214-CT214, 2019 | | 2019 |
| Abstract CT215: Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer S Marsoni, G Germano, AS Bianchi, F Pietrantonio, N Personeni, A Amatu, ... Cancer Research 79 (13_Supplement), CT215-CT215, 2019 | | 2019 |
| Mutational signatures of early-onset colorectal cancer. S Marsoni, F Zanardi, F Iannelli, E Salviato, F Ferrari, P Luraghi, L Lazzari, ... Journal of Clinical Oncology 37 (15_suppl), e15113-e15113, 2019 | | 2019 |
| Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer L Barault, G Germano, S Lamba, G Rospo, A Magri, F Maione, M Russo, ... Cancer Research 78 (13_Supplement), 2743-2743, 2018 | | 2018 |
| Identification of novel therapeutic strtegies for Uveal Melanoma N Amirouchene-Angelozzi Université Paris Sud-Paris XI, 2014 | | 2014 |
